
Articles
-
4 days ago |
techtarget.com | Alivia Kaylor
Ca-ssis/istock via Getty Images Moderna's next-gen COVID-19 vaccine, mNEXSPIKE, has FDA approval for adults 65+ and high-risk individuals aged 12–64, marking the first approval under revised vaccine guidelines.
-
1 week ago |
techtarget.com | Alivia Kaylor
Ca-ssis/istock via Getty Images The FTC has issued warning letters to major pharmaceutical companies over more than 200 Orange Book patent listings linked to brand-name drugs that delay generic competition.
-
1 week ago |
techtarget.com | Alivia Kaylor
Markus Mainka - stock.adobe.com Health Secretary RFK Jr. reverses COVID-19 vaccine recommendations for healthy children and pregnant individuals, sparking concern over vaccination guidance and patient confidence.
-
2 weeks ago |
techtarget.com | Alivia Kaylor
sdecoret - stock.adobe.com An updated FDA COVID-19 vaccine policy ends universal boosters and requires clinical outcome trials for individuals aged between 6 months and 64 years without risk factors.
-
2 weeks ago |
techtarget.com | Alivia Kaylor
Pharmaceutical companies increasingly rely on dense patent thickets, including continuation patents, to delay competition, extend exclusivity and protect profits.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →